'Living fossil' stops HIV in its tracks
Scientists have successfully used ribozymes - considered by some to be the 'living fossils' of a time when life was based on RNA - to prevent the spread of HIV in the body.
Archives for June 5, 2007
Drugs moving into the clinic: 17
The seventeenth in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators.
Managing risk in clinical outsourcing
Sponsors need to ensure they are managing the risk involved in clinical outsourcing, particularly when dealing with multiple contractors.
Valeant sheds final facilties
Valeant Pharmaceuticals has announced that it has found a buyer for two of its manufacturing plants in a final move to complete the restructuring plans announced by the company last year.
Bionovo, Somaxon Pharmaceuticals, Trius Therapeutics, Exelixis, AmerisourceBergen Corporation and Kindred Healthcare - People on the move
Bionovo, Somaxon Pharmaceuticals, Trius Therapeutics, Exelixis, AmerisourceBergen Corporation and Kindred Healthcare have all had people on the move in the world of pharmaceutical manufacturing.
Million Euro milestone for GSK drug
An Italian firm specialising in novel drug delivery technologies is due to receive a lump sum of €1m following the successful development of a new formulation of a GlaxoSmithKline (GSK) drug.
Oxigene's Zybrestat cuts tumour blood flow
Oxigene's potentially first-in-class cancer drug is showing promising clinical results and could rival a drug Novartis' recently spent nearly a billion dollars on.
First Chinese CRO merger announced
Two Chinese contract research organisations (CROs) have announced they will merge - a first in China's CRO industry.